Vadher Ambarish H, Parikh Jolly R, Parikh Rajesh H, Solanki Ajay B
A. R. College of Pharmacy and G. H. Patel Institute of Pharmacy, Vallabh Vidyanagar, 388 120, India.
AAPS PharmSciTech. 2009;10(2):606-14. doi: 10.1208/s12249-009-9221-6. Epub 2009 May 15.
The present study was carried out with a view to enhance the dissolution of poorly water-soluble BCS-class II drug aceclofenac by co-grinding with novel porous carrier Neusilin US(2.) (amorphous microporous granules of magnesium aluminosilicate, Fuji Chemical Industry, Toyama, Japan). Neusilin US(2) has been used as an important pharmaceutical excipient for solubility enhancement. Co-grinding of aceclofenac with Neusilin US(2) in a ratio of 1:5 was carried out by ball milling for 20 h. Samples of co-ground mixtures were withdrawn at the end of every 5 h. and characterized for X-ray powder diffraction, differential scanning calorimetry, and Fourier-transform infrared spectroscopy. The analysis revealed the conversion of crystalline aceclofenac to its amorphous form upon milling with Neusilin US(2). Further, in vitro dissolution rate of aceclofenac from co-ground mixture was significantly higher compared to pure aceclofenac. The accelerated stability study of co-ground mixture was carried out at 40 degrees C/75%RH for 4 weeks, and it showed that there was no reversion from amorphous to crystalline form. Thus, it is advantageous to use a porous carrier like Neusilin US(2) in improvement of dissolution of poorly soluble drugs.
本研究旨在通过与新型多孔载体Neusilin US(2)(硅酸铝镁无定形微孔颗粒,日本富山富士化学工业公司)共研磨来提高难溶性BCS II类药物醋氯芬酸的溶出度。Neusilin US(2)已被用作提高溶解度的重要药用辅料。将醋氯芬酸与Neusilin US(2)按1:5的比例通过球磨共研磨20小时。每5小时结束时取出共研磨混合物的样品,并对其进行X射线粉末衍射、差示扫描量热法和傅里叶变换红外光谱表征。分析表明,与Neusilin US(2)一起研磨后,结晶型醋氯芬酸转变为无定形形式。此外,与纯醋氯芬酸相比,共研磨混合物中醋氯芬酸的体外溶出速率显著更高。对共研磨混合物进行了40℃/75%相对湿度下为期4周的加速稳定性研究,结果表明没有从无定形转变为结晶形式。因此,使用像Neusilin US(2)这样的多孔载体来改善难溶性药物的溶出度是有利的。